News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,847 Results
Type
Article (2118)
Company Profile (22)
Press Release (68707)
Section
Business (31535)
Career Advice (55)
Deals (5109)
Drug Delivery (4)
Drug Development (8252)
Employer Resources (16)
FDA (1253)
Job Trends (1802)
News (44068)
Policy (2373)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (134)
Academic (1)
Accelerated approval (1)
Allergies (13)
Alliances (2521)
ALS (5)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (31)
Approvals (1343)
Artificial intelligence (33)
Autoimmune disease (10)
Bankruptcy (19)
Best Places to Work (1670)
Biosimilars (10)
Biotechnology (17)
Bladder cancer (30)
Brain cancer (5)
Breast cancer (111)
Cancer (640)
Cardiovascular disease (49)
Career advice (49)
CAR-T (10)
CDC (2)
Cell therapy (43)
Cervical cancer (6)
Clinical research (7819)
Collaboration (84)
Compensation (68)
COVID-19 (152)
CRISPR (6)
C-suite (29)
Cystic fibrosis (15)
Data (966)
Depression (9)
Diabetes (48)
Diagnostics (675)
Digital health (5)
Diversity, equity & inclusion (4)
Drug discovery (17)
Drug pricing (7)
Duchenne muscular dystrophy (9)
Earnings (29290)
Employer branding (2)
Employer resources (13)
Events (7334)
Executive appointments (33)
FDA (1783)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (7)
Funding (83)
Gene editing (13)
Generative AI (3)
Gene therapy (54)
GLP-1 (111)
Government (283)
Guidances (263)
Healthcare (2183)
HIV (7)
Huntington's disease (1)
IgA nephropathy (10)
Immunology and inflammation (23)
Immuno-oncology (3)
Indications (17)
Infectious disease (175)
Inflammatory bowel disease (23)
Inflation Reduction Act (1)
Influenza (7)
Intellectual property (19)
Interviews (9)
IPO (3928)
IRA (1)
Job creations (217)
Job search strategy (48)
JPM (5)
Kidney cancer (6)
Labor market (13)
Layoffs (35)
Legal (452)
Liver cancer (13)
Lung cancer (95)
Lymphoma (66)
Machine learning (2)
Management (3)
Manufacturing (38)
MASH (28)
Medical device (1627)
Medtech (1635)
Mergers & acquisitions (1291)
Metabolic disorders (150)
Multiple sclerosis (28)
NASH (2)
Neurodegenerative disease (17)
Neuropsychiatric disorders (12)
Neuroscience (239)
Neurotech (1)
NextGen: Class of 2026 (556)
Non-profit (284)
Now hiring (2)
Obesity (60)
Opinion (11)
Ovarian cancer (15)
Pain (10)
Pancreatic cancer (25)
Parkinson's disease (21)
Partnered (5)
Patents (34)
Patient recruitment (30)
Peanut (7)
People (2157)
Pharmaceutical (4)
Pharmacy benefit managers (3)
Phase 1 (1866)
Phase 2 (3117)
Phase 3 (3324)
Pipeline (1555)
Policy (10)
Postmarket research (341)
Preclinical (590)
Press Release (1)
Prostate cancer (28)
Radiopharmaceuticals (23)
Rare diseases (82)
Real estate (293)
Recruiting (7)
Regulatory (2015)
Reports (13)
Research institute (158)
Resumes & cover letters (6)
Rett syndrome (2)
RNA editing (2)
RSV (11)
Schizophrenia (16)
Series A (13)
Series B (13)
Service/supplier (1)
Sickle cell disease (13)
Special edition (4)
Spinal muscular atrophy (6)
Startups (147)
Stomach cancer (5)
Supply chain (3)
Tariffs (4)
The Weekly (3)
Vaccines (98)
Venture capital (4)
Weight loss (38)
Women's health (9)
Date
Today (12)
Last 7 days (78)
Last 30 days (283)
Last 365 days (4339)
2026 (392)
2025 (4408)
2024 (5259)
2023 (5834)
2022 (6767)
2021 (7020)
2020 (6181)
2019 (4567)
2018 (3450)
2017 (3268)
2016 (2335)
2015 (3078)
2014 (2028)
2013 (1320)
2012 (1753)
2011 (2002)
2010 (1880)
Location
Africa (65)
Alabama (7)
Arizona (17)
Arkansas (2)
Asia (3643)
Australia (618)
California (1584)
Canada (422)
China (109)
Colorado (77)
Connecticut (89)
Delaware (60)
Europe (10382)
Florida (192)
Georgia (66)
Hawaii (1)
Idaho (3)
Illinois (101)
India (7)
Indiana (116)
Iowa (1)
Japan (52)
Kansas (10)
Kentucky (6)
Louisiana (7)
Maine (15)
Maryland (169)
Massachusetts (1003)
Michigan (38)
Minnesota (82)
Missouri (12)
Montana (3)
Nebraska (3)
Nevada (9)
New Hampshire (9)
New Jersey (518)
New Mexico (1)
New York (451)
North Carolina (189)
Northern California (848)
Ohio (30)
Oregon (3)
Pennsylvania (300)
Rhode Island (1)
South America (95)
South Carolina (1)
Southern California (584)
Tennessee (32)
Texas (217)
United States (5465)
Utah (45)
Vermont (1)
Virginia (15)
Washington D.C. (5)
Washington State (152)
Wisconsin (10)
70,847 Results for "47".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference
February 18, 2026
·
1 min read
Press Releases
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference
February 18, 2026
·
1 min read
Layoffs
Biopharmas Axed 47% More Employees Year Over Year
In 2025, made or projected biopharma workforce cuts affected about 42,700 employees, according to
BioSpace
tallies.
BioSpace
takes a deep dive into which companies and locations were impacted and speaks to experts about what to expect ahead—and why.
January 8, 2026
·
5 min read
·
Angela Gabriel
Press Releases
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
January 28, 2026
·
6 min read
Press Releases
Allink Biotherapeutics Completes $47M Extension Rounds of Series A to Accelerate Clinical Programs and Novel Platforms Development
December 17, 2025
·
4 min read
Press Releases
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer
February 1, 2026
·
4 min read
Press Releases
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
February 11, 2026
·
4 min read
Press Releases
ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004
January 9, 2026
·
5 min read
Press Releases
PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets
December 10, 2025
·
5 min read
Press Releases
HanchorBio Secures US Patent for Innovative SIRPα/CD47 Fusion Protein HCB101
October 21, 2025
·
4 min read
1 of 7,085
Next
